Sangamo Therapeutics

SGMO

Market cap $180M

0.5355 USD

+0.0225

4.39%

At close Updated Jan 30, 4:00 PM EST

Pre-market

After hours

0.5061

-0.0294

5.49%

1 day

4.39%

5 days

40.92%

1 month

25.32%

3 months

-6.38%

6 months

-1.74%

Year to date

22.09%

1 year

-56.46%

5 years

-96.2%

10 years

-91.09%

About: Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Employees: 183

Healthcare Biotechnology